Health Plans can facilitate evidence-based medicine
There is ample evidence that the practice of evidence-based medicine (EBM) can lead to more cost-effective healthcare. Healthcare payer organizations should pay attention to potential strategies to help improve the adoption of computer-based patient record (CPR) systems by clinicians. By making reasonable investments in this area, payers have the potential to reap a number of benefits including increased patient satisfaction, increased physician satisfaction, reduced costs and decreased care delivery errors.
There is ample evidence that the practice of evidence-based medicine (EBM) can lead to more cost-effective healthcare. Healthcare payer organizations should pay attention to potential strategies to help improve the adoption of computer-based patient record (CPR) systems by clinicians. By making reasonable investments in this area, payers have the potential to reap a number of benefits including increased patient satisfaction, increased physician satisfaction, reduced costs and decreased care delivery errors.
Emerging third-generation CPR systems are sufficient to support the practice of evidence-based medicine. This is true because a third-generation CPR delivers adequate maturity in:
As third-generation CPRs emerge during 2005, the combination of these seven capabilities will enable care delivery organizations to provide direct point-of-care support for the activities involved in EBM. Physicians will have the opportunity to devise care management protocols, decision support, order sets and workflows that actually implement quality medical care. The system will then help nurses and other caregivers ensure that they are carrying out the needed activities.
Barry Hieb is a research director with Gartner's Healthcare Industry Research & Advisory Services.
Visit http://gartner.com/healthcare or e-mail info@gartner.com
.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
